Strides Pharma Science arm gets US FDA nod for drug to treat overactive bladder
The approved product is a generic version of Vesicare tablets of Astellas Pharma US
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
AstraZeneca India receives marketing permission for QTERN
Once-daily anti-diabetes treatment for adults with type-2 diabetes, QTERN combines two anti-hyperglycaemic agents with…
Cipla launches daptomycin for injection, 500 mg/vial
The single-dose vials are for intravenous use only
Agilent introduces intelligent LC/MS system for chromatographers in India
The intuitive quadrupole incorporates 'designed-in' smart features
Eisai India and Mylan to commercialise teceris
The second eribulin brand in India, teceris aimed at expanding access to metastatic breast cancer patients in India
Lupin gets 3 observations from USFDA for its Tarapur facility
The inspection of Tarapur facility was carried out by the United States Food and Drug administration (USFDA) between September…
Price caps are a band aid hiding larger issues
Pharma companies should not be the ones held responsible for the high prices of medicines
MyMedicineBox collaborates with Paytm First to help chronic patients
The service includes great savings upto 60 per cent on various needs of patients
USV to invest Rs 4,000 mn in new formulation plant at Vadodara
USV has three plants based in Daman and Baddi manufacturing tablets, capsules, sterile injectables and ophthalmic products, one…
Lupin appoints Jon Stelzmiller as President of US Specialty Business
He brings to Lupin over 30 years of experience in the specialty segment, and will be replacing Nicholas Hart